Sean Kim
Stock Analyst at JonesTrading
(0.65)
# 3,218
Out of 4,667 analysts
8
Total ratings
33.33%
Success rate
-14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $0.90 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $10.18 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $1.05 | +471.43% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $1.04 | +476.92% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $8.96 | +190.34% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $2.77 | +152.71% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.90
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.18
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $1.05
Upside: +471.43%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $1.04
Upside: +476.92%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $8.96
Upside: +190.34%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $2.77
Upside: +152.71%